MRUS
Price
$42.41
Change
-$0.04 (-0.09%)
Updated
Dec 24 closing price
69 days until earnings call
VCYT
Price
$41.18
Change
+$0.19 (+0.46%)
Updated
Dec 24 closing price
68 days until earnings call
Ad is loading...

MRUS vs VCYT

Header iconMRUS vs VCYT Comparison
Open Charts MRUS vs VCYTBanner chart's image
Merus
Price$42.41
Change-$0.04 (-0.09%)
Volume$292.19K
CapitalizationN/A
Veracyte
Price$41.18
Change+$0.19 (+0.46%)
Volume$183.6K
CapitalizationN/A
MRUS vs VCYT Comparison Chart
Loading...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRUS vs. VCYT commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRUS is a Hold and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (MRUS: $42.41 vs. VCYT: $41.18)
Brand notoriety: MRUS and VCYT are both not notable
MRUS represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MRUS: 52% vs. VCYT: 23%
Market capitalization -- MRUS: $2.9B vs. VCYT: $1.66B
MRUS [@Biotechnology] is valued at $2.9B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRUS’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • MRUS’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than MRUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRUS’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • MRUS’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than MRUS.

Price Growth

MRUS (@Biotechnology) experienced а -5.55% price change this week, while VCYT (@Medical Specialties) price change was -2.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was +2.66%.

Reported Earning Dates

MRUS is expected to report earnings on Mar 04, 2025.

VCYT is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($2.9B) has a higher market cap than VCYT($1.66B). MRUS YTD gains are higher at: 54.218 vs. VCYT (49.691). VCYT has higher annual earnings (EBITDA): -49.41M vs. MRUS (-228.46M). MRUS has more cash in the bank: 632M vs. VCYT (216M). MRUS has less debt than VCYT: MRUS (11M) vs VCYT (12.6M). VCYT has higher revenues than MRUS: VCYT (361M) vs MRUS (35.9M).
MRUSVCYTMRUS / VCYT
Capitalization2.9B1.66B175%
EBITDA-228.46M-49.41M462%
Gain YTD54.21849.691109%
P/E RatioN/AN/A-
Revenue35.9M361M10%
Total Cash632M216M293%
Total Debt11M12.6M87%
FUNDAMENTALS RATINGS
MRUS vs VCYT: Fundamental Ratings
MRUS
VCYT
OUTLOOK RATING
1..100
6384
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
2375
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
5738
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (40) in the Biotechnology industry is in the same range as MRUS (56). This means that VCYT’s stock grew similarly to MRUS’s over the last 12 months.

MRUS's Profit vs Risk Rating (23) in the Biotechnology industry is somewhat better than the same rating for VCYT (75). This means that MRUS’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's SMR Rating (90) in the Biotechnology industry is in the same range as MRUS (97). This means that VCYT’s stock grew similarly to MRUS’s over the last 12 months.

VCYT's Price Growth Rating (38) in the Biotechnology industry is in the same range as MRUS (57). This means that VCYT’s stock grew similarly to MRUS’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MRUS (100). This means that VCYT’s stock grew similarly to MRUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRUSVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMEAX40.840.43
+1.06%
Victory Integrity Discovery A
VEXPX124.380.96
+0.78%
Vanguard Explorer Inv
TGVRX25.060.06
+0.24%
Thornburg International Equity R3
BACCX12.20N/A
N/A
BlackRock Energy Opportunities Inv C
GISTX35.75N/A
N/A
Goldman Sachs Technology Opps Inv

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CYTK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-0.09%
CYTK - MRUS
35%
Loosely correlated
-0.86%
IMTX - MRUS
35%
Loosely correlated
+0.42%
VCYT - MRUS
34%
Loosely correlated
+0.46%
XENE - MRUS
33%
Poorly correlated
+0.73%
GOSS - MRUS
33%
Poorly correlated
-1.64%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+0.46%
NTLA - VCYT
69%
Closely correlated
-0.41%
VCEL - VCYT
60%
Loosely correlated
+0.47%
AXON - VCYT
58%
Loosely correlated
+1.14%
DNA - VCYT
57%
Loosely correlated
-0.95%
ABCL - VCYT
55%
Loosely correlated
+1.03%
More